Quantum BioPharma is trading at $3.09, up +6.55%, as biotech-sector strength supports the move.
- XBI is up 2.09% during regular trading.
- Sector sentiment is supported by the Argenx–Forte Biosciences acquisition and broader biotech M&A activity.
- Quantum BioPharma reported encouraging preliminary MS imaging signals on August 3, including halfway enrollment progress; no August 6 company-specific catalyst was identified.